| Literature DB >> 24479899 |
Shaun R Seaman1, Menelaos Pavlou, Andrew J Copas.
Abstract
Clustered data commonly arise in epidemiology. We assume each cluster member has an outcome Y and covariates X. When there are missing data in Y, the distribution of Y given X in all cluster members ("complete clusters") may be different from the distribution just in members with observed Y ("observed clusters"). Often the former is of interest, but when data are missing because in a fundamental sense Y does not exist (e.g., quality of life for a person who has died), the latter may be more meaningful (quality of life conditional on being alive). Weighted and doubly weighted generalized estimating equations and shared random-effects models have been proposed for observed-cluster inference when cluster size is informative, that is, the distribution of Y given X in observed clusters depends on observed cluster size. We show these methods can be seen as actually giving inference for complete clusters and may not also give observed-cluster inference. This is true even if observed clusters are complete in themselves rather than being the observed part of larger complete clusters: here methods may describe imaginary complete clusters rather than the observed clusters. We show under which conditions shared random-effects models proposed for observed-cluster inference do actually describe members with observed Y. A psoriatic arthritis dataset is used to illustrate the danger of misinterpreting estimates from shared random-effects models.Entities:
Keywords: Bridge distribution; Immortal cohort inference; Informative missingness; Missing not at random; Mortal cohort inference; Semi-continuous data
Mesh:
Year: 2014 PMID: 24479899 PMCID: PMC4312901 DOI: 10.1111/biom.12151
Source DB: PubMed Journal: Biometrics ISSN: 0006-341X Impact factor: 2.571
Estimates for latent process model and marginal model fitted to psoriatic arthritis data
| latent process model | marginal model | |||||
|---|---|---|---|---|---|---|
| binary part | continuous part | |||||
| Parameter | estim | SE | estim | SE | estim | SE |
| Intercept | −0.9909 | 0.3556 | 0.1748 | 0.0555 | 0.263 | 0.0669 |
| Age at onset | 0.6392 | 0.1538 | 0.0984 | 0.0250 | 0.115 | 0.0267 |
| Female | 2.0037 | 0.3149 | 0.2461 | 0.0523 | 0.100 | 0.0580 |
| PsA disease duration | 0.0166 | 0.0220 | 0.0044 | 0.0032 | 0.004 | 0.0041 |
| Actively inflamed joints | 0.1380 | 0.0465 | 0.0243 | 0.0027 | 0.023 | 0.0045 |
| Clinically deformed joints | 0.0179 | 0.0238 | 0.0051 | 0.0031 | 0.007 | 0.0037 |
| PASI score | 0.1543 | 0.1017 | 0.0257 | 0.0134 | −0.005 | 0.0237 |
| Morning stiffness | 1.5691 | 0.2018 | 0.1620 | 0.0262 | 0.273 | 0.0444 |
| ESR | 0.2971 | 0.1103 | 0.0374 | 0.0126 | 0.065 | 0.0232 |
| Medication: | ||||||
| NSAIDs | 0.2960 | 0.2439 | −0.0181 | 0.0280 | −0.235 | 0.0467 |
| DMARDs | 0.3138 | 0.2197 | 0.0226 | 0.0272 | 0.003 | 0.0442 |
| steroids | 0.9927 | 0.4355 | 0.0481 | 0.0441 | 0.049 | 0.0553 |
| Actively inflamed joints | 0.0003 | 0.0031 | −0.0005 | 0.0002 | 0.0000 | 0.0002 |
| Clinically deformed joints | 0.0018 | 0.0011 | 0.0003 | 0.0001 | 0.0000 | 0.0001 |
| Var( | 4.2641 | 0.9001 | ||||
| 0.2074 | 0.0210 | |||||
| 0.0779 | 0.0039 | |||||